A012103 OptimICE-pCR
Breast Cancer
De-escalation of therapy in early-stage TNBC patients who achieve pCR after neoadjuvant chemotherapy with checkpoint inhibitor therapy.
Key Team Members
Principal Investigator
Research Coordinator
Katharine "Kate" Madden
Accepting Patients
Enrollment Started: July 27, 2023
